Abstract
Correlation between T cell phenotypes, especially activated T cells expressing early (EA1) and late (HLA-DR) activation antigens and clinical features were investigated in 22 patients with systemic lupus erythematosus (SLE) of childhood onset. Percentages of T cells expressing EA1 and HLA-DR in 22 patients with SLE were significantly higher than those in controls. Comparison of T cell phenotypes between patients with active and inactive SLE showed that eight patients with active disease had significantly increased percentages of HLA-DR positive T cells than 14 with inactive disease (P<0.01). Serial examinations showed that the percentages of HLA-DR positive T cells were decreased after therapy in seven with active non-renal or active non-renal and renal diseases but not in one with only active renal disease. A possible significance of T cells expressing EA1 and HLA-DR in the management of patients with SLE is discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- HLA-DR:
-
human leukocyte antigens-DR
- SLE:
-
systemic lupus erythematosus
References
Abdou NI, Sagawa A, Pascual E, Herbert J, Sadhegee S (1976) Suppressor T cell abnormality in idiopathic systemic lupus erythematosus. Clin Immunol Immunopathol 6:192–199
Adelman NE, Watling DL, McDevitt HO (1983) Treatment of (NZBxNZW) F1 disease with anti-I-A monoclonal antibodies. J Exp Med 158:1350–1355
Bresnihan B, Jasin HE (1977) Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus. J Clin Invest 59:106–116
Clement LT, Grossi CE, Gartland L (1984) Morphologic and phenotypic features of the subpopulation of Leu-2+ cells that suppresses B cell differentiation. J Immunol 133:2461–2468
Coleman III WP, Coleman WP, Derbes VJ, Jolly HW Jr, Nesbitt LT Jr (1977) Collagen disease in children. JAMA 237:1095–1100
Hara T, Ishii E, Ueda K, Mizukoshi M (1986) Natural killer activity in cyclic neutropenia. Br J Haematol 64:630–632
Hara T, Jung LKL, Bjorndahl JM, Fu SM (1986) Human T cell activation III. Rapid induction of a phosphorylated 28 KD/32 KD disulfide-linked early activation antigen (EA1) by 12-o-tetradecanoyl phorbol-13-acetate, mitogens and antigens. J Exp Med 164:1988–2005
Hemler ME, Jacobson JG, Brenner MB, Mann D, Stominger JL (1985) VLA-1a: a T cell surface antigen which defines a novel late stage of human T cell activation. Eur J Immunol 15:502–508
Hercend T, Ritz J, Schlossman SF, Reinherz EL (1981) Comparative expression of T9, T10, and Ia antigens on activated human T cell subsets. Hum Immunol 3:247–259
Janeway CA Jr, Carding S, Jones B, Murray J, Portoles P, Rasmussen R, Rojo J, Saizawa K, West J, Bottomly K (1988) CD4+ T cells: specificity and function. Immunol Rev 101:39–80
Koide J (1985) Functional property of Ia-positive T cells in peripheral blood from patients with systemic lupus erythematosus. Scand J Immunol 22:577–584
Lobo-Yeo A, Alviggi L, Mieli-Vergani G, Portmann B, Mowat AP, Vergani D (1987) Preferential activation of helper/inducer T lymphocytes in autoimmune chronic active hepatitis. Clin Exp Immunol 67:95–104
Meislin AG, Rothfield N (1968) Systemic lupus erythematosus in childhood. Analysis of 42 cases, with comparative data on 200 adult cases followed concurrently. Pediatrics 42:37–49
Mizutani H, Tsubakio T, Tomiyama Y, Katagiri S, Tamaki T, Kurata Y, Yonezawa T, Tarui S (1987) Increased circulating Ia-positive T cells in patients with idiopathic thrombocytopenic purpura. Clin Exp Immunol 67:191–197
Morimoto C, Steinberg AD, Letvin NL, Hagan M, Takeuchi T, Daley J, Levine H, Schlossman SF (1987) A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody. J Clin Invest 79:762–768
Raziuddin S, Danial HB, Kelley M (1988) OKT4+T cell abnormality patients with active systemic lupus erythematosus: HLA-DR antigen expression. Clin Immunol Immunopathol 48:42–49
Smolen JS, Chused TM, Leiserson WM, Reeves JP, Alling D, Steinberg AD (1982) Heterogeneity of immunoregulatory T cell subsets in systemic lupus erythematosus. Am J Med 72:783–790
Sugawara T, Sasai K, Furukawa Z, Yabuta K, Inoue N, Kaneko K, Ogiwara A (1988) Studies on nine cases with neonatal lupus erythematosus. J Jpn Pediatr Soc 92:670 (abstr)
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
Taniguchi O (1988) Two-color flow cytometry and its application to autoimmune diseases (in Japanese). Jpn J Clin Med 46:860–866
Volk H-D, Kopp J, Korner IJ, Jahn S, Grunow R, Barthelmes H, Fiebig H (1986) Correlation between the phenotype and the functional capacity of activated T cell in patients with active systemic lupus erythematosus. Scand J Immunol 24:109–114
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hara, T., Hisano, S., Mizuno, Y. et al. Systemic lupus erythematosus of childhood onset: correlation between T cells expressing early and late activation antigens and disease activity. Eur J Pediatr 148, 626–629 (1989). https://doi.org/10.1007/BF00441516
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00441516